JP5146944B2 - Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御 - Google Patents

Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御 Download PDF

Info

Publication number
JP5146944B2
JP5146944B2 JP2007073396A JP2007073396A JP5146944B2 JP 5146944 B2 JP5146944 B2 JP 5146944B2 JP 2007073396 A JP2007073396 A JP 2007073396A JP 2007073396 A JP2007073396 A JP 2007073396A JP 5146944 B2 JP5146944 B2 JP 5146944B2
Authority
JP
Japan
Prior art keywords
irbit
binding
protein
antibody
pnbc1
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007073396A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007284433A (ja
JP2007284433A5 (enExample
Inventor
克彦 御子柴
英明 安東
顕洋 水谷
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
National Institute of Japan Science and Technology Agency
RIKEN
Original Assignee
Japan Science and Technology Agency
National Institute of Japan Science and Technology Agency
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Science and Technology Agency, National Institute of Japan Science and Technology Agency, RIKEN filed Critical Japan Science and Technology Agency
Priority to JP2007073396A priority Critical patent/JP5146944B2/ja
Publication of JP2007284433A publication Critical patent/JP2007284433A/ja
Publication of JP2007284433A5 publication Critical patent/JP2007284433A5/ja
Application granted granted Critical
Publication of JP5146944B2 publication Critical patent/JP5146944B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2007073396A 2006-03-20 2007-03-20 Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御 Expired - Fee Related JP5146944B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2007073396A JP5146944B2 (ja) 2006-03-20 2007-03-20 Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006077607 2006-03-20
JP2006077607 2006-03-20
JP2007073396A JP5146944B2 (ja) 2006-03-20 2007-03-20 Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御

Publications (3)

Publication Number Publication Date
JP2007284433A JP2007284433A (ja) 2007-11-01
JP2007284433A5 JP2007284433A5 (enExample) 2010-05-06
JP5146944B2 true JP5146944B2 (ja) 2013-02-20

Family

ID=38756539

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007073396A Expired - Fee Related JP5146944B2 (ja) 2006-03-20 2007-03-20 Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御

Country Status (1)

Country Link
JP (1) JP5146944B2 (enExample)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2500687A1 (en) * 2002-10-02 2004-04-15 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
JP4219648B2 (ja) * 2002-10-11 2009-02-04 独立行政法人理化学研究所 新規ｉｐ３受容体結合タンパク質とｉｐ３指示薬
CA2503390A1 (en) * 2002-11-01 2004-05-21 Genentech, Inc. Compositions and methods for the treatment of immune related diseases

Also Published As

Publication number Publication date
JP2007284433A (ja) 2007-11-01

Similar Documents

Publication Publication Date Title
Khalyfa et al. Characterization of elongation factor-1A (eEF1A-1) and eEF1A-2/S1 protein expression in normal and wasted mice
US8999660B2 (en) Methods Relating to Mammalian Rictor Polypeptide
US8182809B1 (en) Methods for treating cancer by inhibiting MIC shedding
JP2017512068A (ja) マイトフュージンの方法及び使用
US8252547B2 (en) In vitro control of protein synthesis in mammalian cells by IP3 receptor-binding protein
JP5146944B2 (ja) Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御
JPWO2007018316A1 (ja) 癌の予防・治療剤
WO2003055507A1 (en) Remedies for anorexia or lifestyle-related diseases and method of screening the same
WO2015103026A2 (en) Treatment of neurological disorders
JP5378202B2 (ja) 脳・神経に特異的あるいは神経分化に特異的なバイオマーカー
US20060116505A1 (en) Glucose and/or fructose transporter naglt1 and its gene
US7927786B2 (en) Parkin interacting polypeptides and methods of use
JP5114765B2 (ja) Ｋａｎｋ２遺伝子の癌治療及び癌検出並びに創薬への利用
CA3218359A1 (en) Methods for treatment of neuron degeneration
JP5099534B2 (ja) Ｋａｎｋ３遺伝子の癌治療及び癌検出並びに創薬への利用
US20040068098A1 (en) STR50 and uses thereof
WO2006112456A1 (ja) Grk5パーキンソン病関連遺伝子、およびその利用
JP2003169683A (ja) 新規脱共役蛋白質ｍｔ００２９

Legal Events

Date Code Title Description
A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100323

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100323

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100413

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120529

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120730

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120821

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121019

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20121113

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121120

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151207

Year of fee payment: 3

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees